Diagnostics

NEW BRUNSWICK, N.J. – The statistics are sobering. Nearly 30 million Americans have diabetes, with an estimated 86 million more with pre-diabetes, resulting in $322 Billion annually in medical costs.
 
Johnson & Johnson has been a leader in diabetes management and treatment for years, providing medication and devices to support the needs of the diabetes patient and their caregivers. 

WASHINGTON – With increases in consumer spending expected to remain solid during the remainder of the year, the National Retail Federation on Tuesday increased 2016 retail sales projections by 30 basis points to 3.4% over last year.

Online and other non-store sales, which are included in the overall figure, are expected to increase 7% to 10% year-over-year rather than the 6% to 9% percent forecast earlier.

PARSIPPANY, N.J. – While the U.S. OTC market is not highly dynamic in terms of growth, its competitive landscape has changed significantly over the past five years, with the top 10 rankings shifting in 2015, the Kline Group noted on Monday from its recently published Nonprescription Drugs USA.

SAN DIEGO - This fall, health expert and mobile health entrepreneur Matt Riemann will introduce his latest product, Shae, a health platform designed to both analyze and interpret incoming data from FitBit, Apple Watch and other wearables to make personalized, real-time health recommendations for the user.

COLORADO SPRINGS, Colo. - GMDC on Thursday hosted Sally Manoufar, senior manager Health & Wellness at Johnson & Johnson, and Sara Bender, senior channel marketing manager at Johnson & Johnson, to learn about Johnson & Johnson's diabetes front-end solution as part of the group's lunchtime Infocast Event.

LAKE FOREST, Ill. - Omron Healthcare on Thursday announced the release of the Omron Application Program Interface and invited mobile app developers to participate in open-source collaboration.